CLINICAL TRIAL SUMMARY

MDACC Study No:2010-0317 (clinicaltrials.gov NCT No: NCT00878189)
Title:A PHASE 1 TRIAL OF PF-03084014 IN PATIENTS WITH ADVANCED SOLID TUMOR MALIGNANCY AND T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA
Principal Investigator:Guillermo Garcia-Manero
Treatment Agent:PF-03084014
Study Status:Terminated
Study Description:The goal of Part 1 of this clinical research study is to learn if PF-03084014
will have an effect on T-cell acute lymphoblastic leukemia or lymphoblastic
leukemia.

The goal of Part 2 of this study is to learn if PF-03084014 when given in
combination with dexamethasone will have an effect on T-cell acute
lymphoblastic leukemia or lymphoblastic leukemia.

The safety and tolerability of this PF-03084014 will be tests in both parts.

Hide details for General InformationGeneral Information

Disease Group:Leukemia
Phase of Study:Phase I
Treatment Agents:PF-03084014
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:Pfizer
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Guillermo Garcia-Manero
Dept:Leukemia
For Clinical Trial Enrollment:713-745-3428
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults